Publisher Collections of coronavirus research highlighted on ScienceOpen

File:Novel Coronavirus SARS-CoV-2.jpg - Wikipedia

The fast-paced research that we need to quickly understand the novel coronavirus disease COVID-19 and effectively find treatments has changed how scientists are communicating their results. Many researchers are posting their findings as preprints to speed up data sharing, rather than waiting for peer review and publication in an academic journal. But publishers are also stepping up and providing expedited processes to make peer reviewed information available as fast as possible, collecting all relevant publications together and making those freely accessible during this crisis.

ScienceOpen’s Collection of COVID-19 studies

In order to assist this information campaign and to support our users in their search for relevant information, we have grouped multiple Collection pages for coronavirus- and COVID-19-related publisher content in a special Super Collection Coronaviruses, COVID-19 and SARS-CoV-2.

ScienceOpen’s Super Collection: Coronaviruses, COVID-19 and SARS-CoV-2

The Super Collection includes an automatically updating Novel Coronavirus Disease COVID-19 Collection of coronavirus preprints, articles and books, which already encompasses around 3000 publications of which around 25% are flagged as preprints.

Automatically indexed ScienceOpen’s Novel Coronavirus Disease COVID-19 Collection

Expert-reviewed research

The current explosion of information opens the possibility of misuse. That’s why ScienceOpen is working with publishers to highlight resources that have been vetted by experts through formal peer review. The interactive list of updating literature already includes the following scholarly publishers:

AfricArxiv | AIP Publishing | American Chemical Society | Annual Reviews | Emerald | Future Science Group | Hindawi | IEEE | IOP Publishing | JAMA Network (American Medical Association) | Karger Publishers | Mary Ann Liebert, Inc. | MDPI | The Microbiology Society | PLOS | The Royal Society | Wiley 

Wiley: Novel Coronavirus COVID-19
Karger Publishers: Coronavirus / COVID-19
PLOS: COVID-19 pandemic
ACS: COVID-19 Coronavirus
COVID-19 Research in and about Africa (curated by AfricArxiv)
AIP Publishing: Coronavirus
Annual Reviews: Coronavirus Research
Emerald: Coronavirus
European Respiratory Society: COVID-19
Future Science Group: Coronavirus
Hindawi: COVID-19
IEEE: COVID-19 related research
IOP Publishing: Coronavirus
MDPI: Coronavirus
Mary Ann Liebert: COVID-19 science
The Microbiology Society: Coronaviruses
The Royal Society: Coronavirus (COVID-19)

For publishers & researchers

If you are an academic publisher and would like to add your coronavirus / COVID-19 resources to the page for free, just get in touch with Stephanie Dawson for more information.

How can you get involved as a researcher? If you are an author you can add a lay summary and graphical abstract to your article to reach out to a wider audience. You can also add links to the freely accessible datasets in your article or let users know how the can access the data. You are welcome to peer review any preprint in the system or even just “recommend” and article with one click. If you are interested in creating your own topical Collection to highlight the best research in your field, contact Stephanie Dawson for assistance.

A note from ScienceOpen

With our team in various states of lockdown in Germany, France, Poland, Hungary and the US, we greatly appreciate the efforts of researchers around the world to find treatments during this COVID-19 pandemic. We also sincerely thank all the publishers who are working hard to make expert-vetted content available to the research community and the public and are happy to be able to highlight these efforts. Follow for more publisher Collections in the coming days and weeks. Stay safe everyone!

Headline Image Credit: NIAID-RML, Coronavirus, Flickr CC BY 2.0

2 thoughts on “Publisher Collections of coronavirus research highlighted on ScienceOpen”

  1. Please read the paper, “Quarantine of UV-Shine Itself Instead of Quarantine Infectious Agent as a Physical Control Method is the only Ever-Known Effective Method for Stopping the Spreading Potential of 2019-nCoV in China and Later Possibly Disseminate to the Global”, DOI: 10.21275/SR20228084927
    This paper has been published for more than one month (published on March 5, 2020). The idea presented on the website even earlier to February 5, 2020. ( However, both the paper and the idea still haven’t gotten attention. Possibly most people need multimillion-dollar projects to demonstrate their excellent professional expertise in solving the coronavirus crisis; therefore, don’t interested in such a simple and feasible method.

    From February 5 till today, a lot of people get infected and some die in almost all countries. I don’t know whether we can make a statement that scientists’ motivations to demonstrate their professional excellence and neglect the simple methods do increase worldwide death casualty?

    Now I still emphasize, people should install UV lamps on public regions and require people to enter into the region with personal UV protective hoods. This way can 100% percent solve the coronavirus crisis!
    Governments from diverse nations should quickly issue laws under crisis conditions to mandatorily require all public regions must be equipped with UV lamps. UV protective hoods can be so simple as one layer of dark cloth. Everyone can self make it or purchase some commercial products as a replacement. A $10 UV protective hood is well enough for any unprofessional people to use for more than one year without any problems. They can be thrown into a washing machine like other personal clothes. Much cheaper than conventional masks, hospitals, and chemical sanitation. It is really time for people to understand this method. For those excellent people who interested in developing a drug or a vaccine, they should first work under the protection of this simple method. Otherwise, they will possibly get an infection before they can work out any drug or vaccine.

    Thanks for understanding and implementing!

Leave a Reply

Your email address will not be published. Required fields are marked *